A new report by the World Health Organisation (WHO) has revealed that despite significant progress in developing effective treatments for neurological disorders, there are treatment gaps.
WHO made this known in a statement on Monday, noting that over 75 per cent of people in low-income countries and 50 per cent in middle-income countries cannot access these life-changing medicines.
Director speaks
WHO’s Director for the Department of Mental Health, Brain Health and Substance Use, Dévora Kestel, said accessing essential medicines can greatly improve the lives of people with neurological disorders, but many struggle due to unavailability or high costs.
She said: “The impact of neurological disorders can be significantly decreased and quality of life improved if people living with these disorders are provided access to the essential medicines they need.
Subscribe our newsletter to stay updated
Thank you for subscribing!
Subscribe our newsletter to stay updated
Thank you for subscribing!
